In Cell this week: two waves of Denisovan-human mixing, open chromatin accessibility patterns during embryogenesis, and more.
A proteomic and targeted exome sequencing study of diffuse-type gastric cancer led to proteomic subtypes with distinct mutation, survival, and potential treatment patterns.
In PLOS this week: genetic variants associated with HIV infection risk, protein biomarkers of schistosomiasis, and more.
In PLOS this week: COLEC10 linked to craniofacial development, transcripts and peptides of spider venom, and more.
The WUSTL-developed method detects a bile acid that is found at increased levels in Niemann-Pick patients, and is ready for pilot testing, its developers said.
At next week's workshop on the validation of LC/MS-based protein and peptide tests, the FDA hopes to determine what it needs to demand from test developers.
Agilent will provide technology and training for the jointly-run lab, expanding on a 2011 deal to open a microarray technology center at Monash University Malaysia.
Scientists from the Okinawa Institute of Science and Technology and Kyoto University have found 14 metabolites whose levels differ in older individuals' blood.
The announcement comes as the agency is preparing to regulate laboratory developed tests as medical devices, including those based on mass spectrometry.
Advion is opening a new services facility in Indianapolis, and Eli Lilly will transition its drug discovery bioanalytical capability to the firm.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Genetic genealogy has led to an arrest in another cold case, dating back to 1987.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.
Wired reports that 23andMe is trying to bolster its outside collaborations.